↓ Skip to main content

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.

Overview of attention for article published in Haematologica, October 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
66 Mendeley